Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia (A randomized Phase III study conducted by the AIEOP-BFM study group)
Protocol ID
Study10
Disease (Sub Disease)
Lymphoblastic leukaemia
Diagnosis Stage
Newly diagnosed
Location
NSW
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
University Medical Centre Schleswig-Holstein, Germany
University Medical Centre Schleswig-Holstein, Germany
Links
Trial Status
Open
Sites
The Children's Hospital at Westmead
Sydney Children's Hospital
Sydney Children's Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 17 Years
International registry ID's
NCT03643276
| Study Title | International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia (A randomized Phase III study conducted by the AIEOP-BFM study group) |
|---|---|
| Protocol ID | Study10 |
| Disease (Sub Disease) | Lymphoblastic leukaemia |
| Diagnosis Stage | Newly diagnosed |
| Location | NSW |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ University Medical Centre Schleswig-Holstein, Germany |
| Links | https://clinicaltrials.gov/ct2/show/NCT03643276 |
| Trial Status | Open |
| Trial Open Date | 15/07/2018 |
| Sites | The Children's Hospital at Westmead / Sydney Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | up to 17 Years |
| International registry ID's | NCT03643276 |